Study suggests coenzyme Q10 slows functional decline in Parkinsons disease
Results of the first placebo-controlled, multicenter clinical trial of the compound coenzyme Q10 suggest that it can slow disease progression in patients with early-stage Parkinson's disease (PD). While the results must be confirmed in a larger study, they provide hope that this compound may ultimately provide a new way of treating PD....... The phase II study, led by Clifford Shults, M.D., of t...Emory to receive more than $6.5 million to study environmental risk factors for Parkinsons disease
... Emory University, the University of California at Los Angeles and The Parkinson's Institute, Sunnyvale, CA, will each receive more than $6.5 million to create new...UCLA scientists image how Parkinsons genes misfire in mice
UCLA scientists have developed a fast new way to image how thousands of genes misfire proteins in a mouse model of Parkinsons disease. The approach may provide a research blueprint for pinpointing the abnormal brain regions linked to autism and schizophrenia.... ...The new findings are reported in the June edition of Genome Research.... ...Last year, UCLA pharmacologist Desmond Smith developed a....In struggling to find the cause of Parkinsons disease, scientists have recently homed in on a mysterious protein called alpha-synuclein. Researchers suspect abnormal activity of alpha-synuclein is involved not only in inherited, but also in non-inherited forms of the devastating disease. In the January issue of Genome Research, Robert Nussbaum and colleagues from the National Institutes of He...Parkinsons disease is more than just a brain disorder
. For many years, researchers have known that the movement problems associated with . Parkinsons disease result from a loss of neurons that produce a nerve-signaling chemical . called dopamine in one part of the brain. A new study suggests that Parkinsons disease . (PD) also affects nerve endings that produce a related chemical, norepinephrine, in the . heart. The finding improves understandin...Cultured Neural Stem Cells Reduce Symptoms In Model Of Parkinsons Disease
.For decades, researchers have imagined treating human diseases by replacing.damaged cells with stem cells -- embryonic cells from which all other kinds of.cells develop. While the potential benefits are enormous, such strategies have.been limited by an uncertain supply of stem cells. Now, scientists have shown.that neural stem cells can be multiplied and raised to maturity in the.laboratory a...